Impact of cardiac rehabilitation on depression and its associated mortality

Richard V Milani1, Carl J Lavie

  • 1Department of Cardiology, Ochsner Medical Center, New Orleans, La 70121, USA. rmilani@ochsner.org

Insights

Cardiac rehabilitation significantly reduces depressive symptoms in coronary patients. This intervention also lowers the excess mortality associated with depression after cardiac events, even with modest fitness improvements.

Area of Science:

  • Cardiology
  • Psychiatry
  • Rehabilitation Medicine

Background:

  • Depression post-cardiac events correlates with increased mortality.
  • The efficacy of cardiac rehabilitation in mitigating this depression-related mortality is not well-established.

Purpose of the Study:

  • To assess the impact of cardiac rehabilitation on depression in coronary patients.
  • To determine if cardiac rehabilitation reduces depression-associated mortality.

Main Methods:

  • A cohort of 522 coronary patients undergoing cardiac rehabilitation was compared to 179 controls.
  • Depressive symptoms were measured pre- and post-rehabilitation.
  • Mortality was tracked over a mean follow-up of 1296 days.

Main Results:

  • Depressive symptoms decreased by 63% post-rehabilitation (17% to 6%).
  • Depressed patients completing rehabilitation had 73% lower mortality compared to controls.
  • Reductions in depression and mortality were linked to fitness improvements, with modest gains being sufficient.

Conclusions:

  • Cardiac rehabilitation effectively reduces depressive symptoms in patients after coronary events.
  • The intervention significantly lowers the excess mortality linked to post-event depression.
  • Even minor improvements in physical fitness during rehabilitation yield substantial benefits for depression and mortality.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...